Most men on testosterone replacement in Australia have never had a physician sit with them, look at the full picture, and take genuine ownership of their care. They have a prescription. They do not have a doctor.
Testosterone prescriptions have risen sharply. The standard of care has not kept pace.
Australia has seen a dramatic increase in testosterone prescribing over the past decade. Telehealth clinics have made access faster and, in many cases, cheaper. For men who were previously dismissed by GPs or left waiting months for an endocrinology referral, this has been a genuine improvement.
But faster access is not the same thing as better care. What most men encounter — whether through a telehealth platform or a traditional prescriber — is a transactional model. Bloods are ordered on a fixed schedule. Scripts are issued based on numbers. The quarterly consult lasts ten minutes. No one asks about sleep architecture, cardiovascular risk, metabolic health, relationship strain, or what the man actually wants from treatment. The prescription arrives. The physician disappears.
For a therapy that is typically lifelong, that suppresses the body's own production, and that carries real implications for fertility, haematology, and cardiovascular health — this level of care is not adequate. It is merely convenient.
The problems that no one raises until they become urgent.
In my experience, men on TRT through volume clinics consistently encounter the same gaps. Not because the clinics are malicious, but because the model is built for throughput, not depth.
Fertility is treated as an afterthought. Many men under 45 begin testosterone replacement without a clear conversation about the impact on spermatogenesis. By the time they want to start or grow a family, their options have narrowed — sometimes severely. Fertility preservation, HCG co-administration, and the decision framework around these choices should happen before the first injection, not after a crisis.
Monitoring becomes a billing exercise. Quarterly blood panels are standard practice, but the question is whether anyone is genuinely interpreting the trend — or simply confirming that numbers remain within a reference range. Haematocrit creep, oestradiol shifts, PSA trajectory, and the interplay between these markers require clinical judgment, not checkbox reviews.
The underlying picture is ignored. Testosterone sits within an endocrine system, not above it. Thyroid function, cortisol patterns, insulin resistance, sleep apnoea, and chronic stress all influence how a man responds to TRT — and whether he needed it at all. A responsible TRT programme begins with a thorough diagnostic assessment, not a single blood test and a symptom questionnaire.
The "borderline" man is abandoned. Many men present with total testosterone levels that fall within the lower end of the reference range but report significant symptoms — fatigue, cognitive fog, diminished drive, sexual dysfunction. Rigid PBS criteria exclude them. Conservative GPs tell them it is stress. Telehealth clinics may treat them, but often without the broader workup that would distinguish genuine hypogonadism from a treatable underlying cause. These men deserve a thorough evaluation, not a binary gatekeeping decision.
What TRT looks like inside a physician relationship.
CURA is a physician membership for men, capped at seventy members across Auckland and Melbourne. Testosterone management is one part of a comprehensive, longitudinal physician relationship — not a standalone product.
What this means in practice:
Your physician knows you. Not your file — you. Your history, your goals, your family situation, your risk profile, and what you are trying to achieve with treatment. This is not a rotating roster of locums reviewing your bloods for the first time.
The diagnostic assessment comes first. Every member begins with a Men's Health Strategy Session — a comprehensive clinical evaluation that maps cardiometabolic, hormonal, sexual, and cognitive health before any treatment decisions are made. If testosterone replacement is appropriate, it is initiated with the full clinical picture in view. If something else explains your symptoms — and frequently, something does — we find it.
Fertility is addressed from day one. For any member under 45 considering TRT, fertility preservation is a proactive conversation, not a reactive one. We discuss semen analysis, HCG protocols, and long-term reproductive planning as part of the initial treatment framework.
Monitoring is driven by clinical judgment. We do not run quarterly panels because a billing schedule demands them. We monitor based on your clinical trajectory — more frequently when initiating or adjusting, less frequently when stable. Every result is reviewed by your physician in the context of your full history and discussed with you directly.
You have direct access to your physician. Not an admin team. Not a ticketing system. When you have a question about your treatment, you reach your doctor. This is a foundational commitment of the model — not a premium add-on.
This model is not for everyone.
CURA membership is structured to sustain a practice that sees fewer men, spends more time, and does not compromise on depth. If your primary concern is finding the lowest-cost testosterone prescription, there are competent telehealth providers who can serve you well. We are not in competition with them.
We exist for the man who has realised that a prescription is not the same thing as care — and who wants a physician willing to take genuine ownership of his health.